1070321

Dendreon Pharmaceuticals LLC — FEI 3008914686

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 22, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Union City, GA (United States)

Citations

IDCFRDescription
7821 CFR 606.100(c)Record review prior to release
93221 CFR 123.7(d)Corrective action documentation